Latest News on Pfizer Inc. (PFE) Stock

  • Merck lagging this year, but charts show it's poised for ... [December 11 2017 03:42 PM]
  • Carter Worth, Cornerstone Macro, discusses one lagging stock that could make a comeback. Read more about this Pfizer Inc. (PFE) news
  • Roche's Fight With Pfizer May Be Just The Beginning [December 11 2017 01:55 PM]
  • Roche recently sued Pfizer to block the latter’s biosimilar (generic version) for Herceptin- a cancer biologic that earned $2.5 billion in sales in the U.S. for Roche in 2016. The fight is unlikely to stop there for Roche, as it has a lot more at stake. Read more about this Pfizer Inc. (PFE) news




  • [$$] Spark Therapeutics Selloff Looks Overdone [December 11 2017 11:05 AM]
  • Spark Therapeutics shares have plunged today, falling $27, or 37%, to $44.03 after the gene-therapy company released disappointing results for its treatment for hemophilia A at the American Society of Hematology’s annual meeting in Atlanta. The data on four patients in a phase 1/2 clinical trial showed some variability in the expression of Factor VIII, the clotting protein either missing or exi... Read more about this Pfizer Inc. (PFE) news

Looking for Market Opportunties?


Today's Most Active Stocks
Today's Biggest Price % Gainers
Today's Biggest Price % Losers
Today's Unusual Rising Volume Stocks
Today's Unusual Falling Volume Stocks
Research Reports
Earning Calendar
ETF Center